Overview

Ginsenoside-Rd for Acute Ischemic Stroke

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Xijing Hospital
Criteria
Inclusion Criteria:

- between 18 to 75 years

- the first episode

- from onset to admission within 72 hours

- NIHSS scores:5~22

Exclusion Criteria:

- had other intracranial pathologies (e.g., tumor, infection)

- had a neurologic or psychiatric disease

- had a coexisting condition that limited their life expectancy

- had significant drug or alcohol misuse

- had high-grade carotid artery stenosis for which surgery was planned

- were pregnant or nursing

- participated in a clinical trial with an investigational drug or device within the
past 3 months

- were unlikely to be available for follow-up